Related Experiment Videos
Development and evaluation of electrically actuated abdominal left ventricular assist systems for long-term use
Summary
A novel abdominally positioned left ventricular assist system (ALVAS) shows excellent early results in calves, demonstrating promising mechanical reliability and biocompatibility for advanced heart failure patients.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Medical Device Development
Background:
- End-stage heart failure requires advanced therapeutic options.
- Conventional treatments are often insufficient for refractory cases.
- Implantable assist devices offer potential solutions.
Purpose of the Study:
- To develop and evaluate a long-term, totally implantable, electrically actuated, abdominally positioned left ventricular assist system (ALVAS).
- To assess the in vitro and in vivo performance of the ALVAS in preclinical models.
Main Methods:
- Integration and in vitro characterization of the pusher-plate blood pump and energy converters.
- Long-term in vivo evaluation of the integrated ALVAS in calves.
- Assessment of hemodynamic effectiveness, mechanical reliability, and biocompatibility.
Main Results:
- The ALVAS has been evaluated in vivo for over 6 months in calves.
- System performance has been excellent regarding hemodynamic effectiveness.
- Mechanical reliability and biocompatibility have been excellent, with no observed adverse effects.
Conclusions:
- The abdominally positioned left ventricular assist system (ALVAS) demonstrates excellent short-term performance and safety in a preclinical model.
- Further studies are ongoing to establish long-term effectiveness.
- A 2-year clinical use goal is targeted for this advanced cardiac assist technology.